NCT00385333View on ClinicalTrials.gov

Metabolic Mapping to Measure Retinal Metabolism

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 29, 2006

Primary Completion Date

June 1, 2008

Study Completion Date

September 16, 2010

Conditions
Macular DegenerationDiabetic RetinopathyHippel-Landau DiseaseMitochondria
Interventions
PROCEDURE

Feasibility Study - Imaging System

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00385333 - Metabolic Mapping to Measure Retinal Metabolism | Biotech Hunter | Biotech Hunter